Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Four Points Innovation is a private company aiming to accelerate drug discovery and development.
Contessa operates Home Recovery Care, combining all the essential elements of inpatient hospital care in the comfort of patients’ homes.
GrayBug is a biopharmaceutical company that develops transformative medicines for ocular diseases.
Chondrial Therapeutics is clinical-stage biotechnology that focuses on developing orphan drugs for mitochondrial diseases.
TriNetX is a health research network that connects drug discovery and development from pharmaceutical companies.
Stelexis Therapeutics is a company utilizes pre-cancerous stem cells to discover and develop transformative therapies.
Blade Therapeutics is a discovery stage drug development company.
Pinnacle Hill is the drug spinout company.
Poseidon Innovation is a provider of advance disease curing therapeutics for risky early-stage processes.
Lakeside Discovery accelerates the translation of transformative biomedical technologies.
Company that will support Vanderbilt’s innovative life science research .
We transform the management of OUD to help people begin and sustain recovery.
Concert Genetics provides physicians with the information they need to find the right test for their patients.
Vensun Pharmaceuticals is a pharmaceutical company developing generic prescription products in various dosage forms.
Recovery Centers of America is fundamentally transforming the treatment of addiction and the capabilities of those in recovery
TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.
New American Therapeutics is a specialty pharmaceutical company that acquires, markets and develops products in select therapeutic areas.
Deerfield has invested in 161 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Deerfield's top investment sectors include Health Care, Biotechnology, Pharmaceutical, Therapeutics, Medical. The firm invests across 19 different industry categories.
Among tracked funding rounds, TESARO received $409.0M in a Post Ipo Equity round. Deerfield's total known invested capital is $7.9B.
Deerfield's average investment size is $79.0M across its portfolio of 161 companies.